Open Beta
TREN
MetriLume
TREN

US marketsLSTA

SEC-sourced researchBeta

LSTA

LISATA THERAPEUTICS, INC.

Company comparison ↗

Data passport

CIK
0000320017
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 1,000,000.0000 USD; December 2025: 170,000.0000 USD1M USD0 USD0December 2024December 2025
LSTA · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20241,000,000.0000Mar 12, 2026
December 2025170,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025170,000.0000-16,586,000.0000-15,949,000.000017,744,000.00003,143,000.0000Mar 12, 2026
December 20241,000,000.0000-19,985,000.0000-19,356,000.000035,002,000.00005,685,000.0000Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$170KDecember 2025Mar 12, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$1MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss-$16.59MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$15.95MDecember 2025Mar 12, 202610-K
Total assetsAssets$17.74MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$3.14MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗